Dyfyniad APA

Ghanem, H., Cornelison, A. M., Garcia-Manero, G., Kantarjian, H., Ravandi, F., Kadia, T., . . . Jabbour, E. (2013). Decitabine Can Be Safely Reduced after Achievement of Best Objective Response in Patients with Myelodysplastic Syndrome.

Dyfyniad Arddull Chicago

Ghanem, Hady, et al. Decitabine Can Be Safely Reduced After Achievement of Best Objective Response in Patients With Myelodysplastic Syndrome. 2013.

Dyfyniad MLA

Ghanem, Hady, et al. Decitabine Can Be Safely Reduced After Achievement of Best Objective Response in Patients With Myelodysplastic Syndrome. 2013.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.